Obesity is a widespread epidemic in the United States, affecting 42.4 percent of Americans in 2018 (). This condition is defined by an excess of body fat that causes a body mass index reading of 30 or higher. Without obesity treatment, the disease can lead to several other severe medical conditions, including diabetes, heart disease,…
The ongoing COVID-19 pandemic has pushed wellness to the front of people’s minds. However, amidst constant public health messaging that encourages frequent hand washing and strict physical distancing, we’ve also seen another important message emerge: mental health matters too. In this uncertain time, health experts are more focused than ever on promoting behaviors that keep…
After receiving FDA approval in 2012, Belviq and Belviq XR (lorcaserin) rose to fame as a sustainable, pharmaceutical option for overweight and obese individuals interested in weight loss. The prescription-only medication worked by increasing feelings of fullness to help patients eat less, but new research suggests that long-term use may have also increased cancer risk….
A study revealed that generic phentermine, a popular weight loss drug, may be safe and effective for longer-term treatment. Researchers at Wake Forest Baptist Health and the PORTAL Network analyzed data from the electronic health records of over thirteen thousand adults who were prescribed generic phentermine for short-term use versus longer-term use of a year…
VIVUS Inc. – the manufacturer of Qsymia weight loss pills – released a press release on Monday that announced the results of a promising retroactive study on Qsymia safety. Authors concluded that the risk of major adverse cardiovascular events, such as heart attack and stroke, is lower when taking Qsymia, generic phentermine & topiramate (combined),…